Daxor Publishes Results of its BVA-100 Blood Volume Diagnostic for Heart Failure
- The study evaluates the relationship between cardiac filling pressures & TBV measurement in heart failure patients by using Daxor’s BVA-100 blood test vs commercially available PADP monitor between sexes & LVEF
- The results from the study depicted a lack of correlation between pressure measures & actual blood volume as there was no significant difference between PADP & TBV. The intracardiac pressure & intravascular volume were disassociated across both sexes & LVEF
- The study showed that direct volume measurement was more accurate vs pressure measures. Additionally, Daxor published the data in the ‘Journal of Cardiovascular Translational Research’
Ref: Globenewswire | Image: Daxor
Neha is a Senior Editor at PharmaShots. She is passionate and very enthusiastic about recent updates and developments in the life sciences and pharma industry. She covers Biopharma, MedTech, and Digital health segments along with different reports at PharmaShots. She can be contacted at firstname.lastname@example.org.